News

All current DZIF news can be found here.

Cryo-electron microscopic reconstruction of molecular structures: On the left, the vertical representation of the binding of a yellow-coloured antibody to the blue-coloured tip of the secretion system shown in grey. On the right, a top view of the binding structure, showing how the yellow antibody binds laterally to the blue tip of the secretion system, which is round in top view.

Neutralising antibodies that target resistant bacteria

Antibiotic-resistant bacteria pose a major challenge to healthcare systems worldwide. Due to numerous resistance mechanisms, infections with the pathogen Pseudomonas aeruginosa are particularly feared

An Indian female lab technician holds the test cartridge tested in the study in her right hand.

New tool makes it easier to diagnose tuberculosis in children

Around 240,000 children worldwide die of tuberculosis every year. The disease is among the top ten causes of death in children under the age of five. One of the main reasons for this mortality is that

Whitish Acinetobacter baumannii colonies on a red agar plate

Avoiding the further spread of carbapenem-resistant Acinetobacter baumannii

Researchers from the German Center for Infection Research (DZIF) at the University of Cologne have conducted a study on the carbapenem-resistant bacterium Acinetobacter baumannii. The pathogen was

Der Preisträger Ralf Bartenschlager steht in der Mitte des Bildes, rechts neben ihm steht Nadja Käding von der DZIF Academy, links neben Prof. Bartenschlager steht DZIF-Vorstandsvorsitzender Prof. Dirk Busch.

Virologist Ralf Bartenschlager honoured with the DZIF Prize for Translational Infection Research

The German Center for Infection Research (DZIF) honours the virologist Prof. Dr Dr h. c. Ralf Bartenschlager from the Heidelberg University Hospital. The DZIF Prize for Translational Infection

Successfully promoting new approaches to antibacterial therapies: INCATE celebrates its two-year anniversary

The INCubator for Antibacterial Therapies in Europe, INCATE, can point to an impressive series of successes on its two-year anniversary. With direct contact to more than 180 start-ups and initiatives

The photo shows a group of four researchers (three women and one man) in white lab coats in a laboratory.

Researchers decode new antibiotic agent

More and more bacterial pathogens are developing resistance. There is an increasing risk that current drugs will no longer be effective against infectious diseases. Scientists around the world are

Schematic representation of a liver (in brown-orange) surrounded by round virus particles and blood cells (in white-gray).

A promising investigational therapeutic monoclonal antibody to treat chronic hepatitis B and D infections

Affecting hundreds of millions of people, chronic hepatitis B is a widespread global health problem for which there is as yet no cure. In a preclinical study involving the German Center for Infection

Measles-based vector vaccine protects mice against influenza A (H7N9) virus

Researchers of the German Center for Infection Research (DZIF) at the Paul-Ehrlich-Institut (PEI) and Philipps-Universität Marburg used the "recombinant measles virus" vaccine platform to test vaccine

Several silver-coloured bioreactors with many connecting tubes and control screens used for fermentation and production of active agents.

Clinical development of two antimicrobial agents funded by Else Kröner-Fresenius Foundation

The Else Kröner-Fresenius Foundation's ForTra gGmbH for Research Transfer—the largest medicine-funding foundation in Germany—supports the legally compliant production of new drug candidates for direct

Prof. Wedemeyer and Prof. Cornberg stand next to each other. Together they are holding a laboratory book in their hands. A laboratory can be seen in the background, slightly blurred.

New weapon against hepatitis D

In a multicentre phase 3 trial, researchers at the MHH have demonstrated the efficacy and safety of the drug Bulevirtide, which prevents Hepatitis D viruses from entering the liver.

Infection with